non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer#414481ClinicalTrials.gov
• Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer#245492ClinicalTrials.gov
• Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade#152420ClinicalTrials.gov
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer#623527ClinicalTrials.gov
• Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors#383548ClinicalTrials.gov
• AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer#838145ClinicalTrials.gov
• A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer#201596ClinicalTrials.gov
• Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC#830554ClinicalTrials.gov
• Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)#838243ClinicalTrials.gov
• High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations#813557ClinicalTrials.gov
• LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG#195333ClinicalTrials.gov
• TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy#314343ClinicalTrials.gov
• Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer#300239ClinicalTrials.gov
• Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)#840475ClinicalTrials.gov
• Neoadjuvant Immunotherapy in Advanced NSCLC#474755ClinicalTrials.gov
• TEIPP Immunotherapy in Patients With NSCLC#674903ClinicalTrials.gov
• Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer#411409ClinicalTrials.gov
• CT radiomics-histopathological correlation for mediastinal lymph node staging in non-small cell lung cancer#643091HAL (France)
• An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)#811205ClinicalTrials.gov
• Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients#831093ClinicalTrials.gov
• Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer#245498ClinicalTrials.gov
• AMT-116 in Combination With Ivosidan in Patients With Lung Cancer#356471ClinicalTrials.gov
• Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer#366616ClinicalTrials.gov
• FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy#640571ClinicalTrials.gov
• AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer#833943ClinicalTrials.gov
• Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer#825945ClinicalTrials.gov
• Safety Study of SEA-CD40 in Cancer Patients#837685ClinicalTrials.gov
• A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma#833791ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer#195393ClinicalTrials.gov
• Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking#837456ClinicalTrials.gov
• Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer#840490ClinicalTrials.gov
• Modifying Your Diet to Support Muscle During Cancer Treatment.#67881ClinicalTrials.gov
• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)#127580ClinicalTrials.gov
• PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1#136340ClinicalTrials.gov
• Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer#162469ClinicalTrials.gov
• First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy#172301ClinicalTrials.gov
• Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis#215395HAL (France)
• Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED)#230397ClinicalTrials.gov
• Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer#267994ClinicalTrials.gov
• Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy#471444ClinicalTrials.gov
• A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy#633725ClinicalTrials.gov
• A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer#826221ClinicalTrials.gov
• A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology#830388ClinicalTrials.gov
• MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)#238109ClinicalTrials.gov
• Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence#801079ClinicalTrials.gov
• Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative#148766ClinicalTrials.gov
• Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer#217013ClinicalTrials.gov
• Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study#833194ClinicalTrials.gov
• dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.#826226ClinicalTrials.gov
• ITIL-168 in Advanced Solid Tumors#325305ClinicalTrials.gov